All News
Two Psoriatic Arthritis Studies: Dr Robert Chao (@doctorRBC)
Dr. Robert Chao discusses abstracts #0375 and #0381 as presented Friday at the #ACR20 annual meeting.
https://t.co/9VpvS1eE2u https://t.co/z2pshtzDeZ
Links:
Dr. John Cush RheumNow ( View Tweet)
So excited to check out RheumNow’s ACR Mid-Meeting Recap live right now with Dr. Jack Cush (@rheumnow), Dr. Arthur Kavanaugh, Dr. Michale Pillinger, and Dr. Bella Mehta! #ACR20
Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
This single slide tries to summarise all major phase3 clinical trials in Psoriatic Arthritis 💪
Take your time. The top half looks at joint efficacy. The bottom half for skin efficacy.
#ACR20 https://t.co/FXhJunXNKt
Dr Irwin Lim _connectedcare ( View Tweet)
RheumNow’s expanded coverage of the #ACR20 Annual meeting is sponsored in part by @Novartis. All content chosen by RheumNow + its Faculty.
Dr. John Cush RheumNow ( View Tweet)
EQUATOR2 52wk extension trial - Filgotinib on enthesitis in PsA pts
1️⃣Clinical resolution of enthesitis at 52wks 77% by LEI and SPARCC
2️⃣Pts who did not respond by wk 16➡️77% and 81% resolution enthesitis by LEI and SPARCC
@RheumNow #ACR20 Abs#0910 https://t.co/mCe32rrAcc
Robert B Chao, MD doctorRBC ( View Tweet)
Health plan claims data appears useful to classify inadequate responders in PsA and should be studied further. #ABS0898 #ACR20 @RheumNow https://t.co/jXBr54Fc6Z https://t.co/fAESyo5Uad
Dr. Rachel Tate uptoTate ( View Tweet)
Neihulizumab, novel immune checkpoint agonistic ab that binds to human CD162 (PSGL-1), thereby preferentially inducing apoptosis in late stage activated T cells. Phase II trial shows efficacy in PsA, further trials to come. #ABS0894 #ACR20 @RheumNow https://t.co/gzf7epPyNd https://t.co/ArLlCyzLxR
Dr. Rachel Tate uptoTate ( View Tweet)
Australian study looking at clinical outcomes following in-class switching vs switching MOA. Rapid effect of IL-17i and JAKi with PsA rated highly. This study highlights ever-growing need for precision medicine based on domain. #ABS09003 #ACR20 @RheumNow https://t.co/7qKH6aw6f0
Dr. Rachel Tate uptoTate ( View Tweet)
BKZ tx improved BASDAI total and single question scores related to fatigue and neck, back and hip pain in pts with PsA. #ABS0906 #ACR20 @RheumNow https://t.co/GzpJfkwvL5 https://t.co/KnJAqAKlqq
Dr. Rachel Tate uptoTate ( View Tweet)
In the search for biomarkers in PsA, interesting study showing absolute lymphocyte count is negatively correlated with cardiovascular disease risk score and red cell distribution width and increases with TNF-Inhibitor Therapy @rheumnow #ACR20 Abstr#878
Dr. Antoni Chan synovialjoints ( View Tweet)
Dr. J. Walsh slide on PROs in PsA research. #ACR20 @RheumNow https://t.co/v4ufUdWufB
Dr. Rachel Tate uptoTate ( View Tweet)
RheumNow’s expanded coverage of the #ACR20 Annual meeting is sponsored in part by Novartis. All content chosen by @RheumNow and its Faculty.
Dr. John Cush RheumNow ( View Tweet)
FUTURE2 analysis of 78 TJC and 76 SJC scores in PsA pts treated with SEC demonstrated improvements in synovitis at Week 24 sustained over 5 years, irrespective of TNFi history & concomitant MTX use. #ABS0875 #ACR20#ACRbest @RheumNow https://t.co/U8B50PTWET https://t.co/fUK1JO10ox
Dr. Rachel Tate uptoTate ( View Tweet)
CORRONA: Majority of PsA pts who initiated an advanced therapy had mild to moderate skin involvement. Decision to change therapy w/ rheumatologist based mainly on MSK symptoms. #ABS0873 #ACR20 @RheumNow https://t.co/mOXg5B7goI https://t.co/mqddMYQ3i0
Dr. Rachel Tate uptoTate ( View Tweet)
Comparative Efficacy of Guselkumab in Patients with Psoriatic Arthritis: Results from Systematic Literature Review and Network Meta-Analysis https://t.co/hgPDtFRxer #PsA #Guselkumab
Peter Nash drpnash ( View Tweet)
Think of Psoriatic Arthritis in the context of Psoriasis https://t.co/XpTFdzEHEa
Dr. Antoni Chan synovialjoints ( View Tweet)
Check out this session at 4 pm EST today on “Psoriatic Arthritis: Treatment in Practice” detailing emerging therapies and co-management strategies by this amazing team! #ACR20 @RheumNow https://t.co/baNtDLe6Rc
Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
Dr. Siri will see you now...🤖
Machine learning identified 9 signatures including nail pso, CRP and 7 biomarkers to distinguish PsA from PsO pts without arthritis and will help diagnose PsA early.
➡️will need to test independent data
@RheumNow #ACR20 Abs#0502
Robert B Chao, MD doctorRBC ( View Tweet)
Our paper on body composition in #PsoriaticArthritis #PsA is now published in @RheumJnl
Results show increased visceral fat in PsA similar to type 2 diabetes in @uk_biobank
Important implications for management.
@iiiglasgow @UofGICAMS @AMRAMedical
https://t.co/6vfkz78tzC
Stefan Siebert StefanSiebert1 ( View Tweet)
Newly discovered HGF & HGFAC genes differentiate PsA and PsO in genetic analysis. Could these be important additional biomarkers for dz? #ABS0500 #ACR20 #ACRbest @RheumNow https://t.co/TNEQo6d6mk https://t.co/bQFBzYmV0J
Dr. Rachel Tate uptoTate ( View Tweet)
